PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells

Yufeng Wang(Yamaguchi University), Kazuyuki Nakamura(Yamaguchi University)
International Journal of Oncology
December 14, 2016
Cited by 117


Related Papers